Skip to Main Content

Author Details

John M Kane
Roswell Park Comprehensive Cancer Center
1993
88
31
PMIDPaper TitleJournal TitlePublished Year
36323987ASO Visual Abstract: Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas-A Systematic Review of the Literature.Ann Surg Oncol2023
37149545Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma.Ann Surg Oncol2023
36995690Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.JAMA Oncol2023
36307665Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature.Ann Surg Oncol2023
34364714Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis.Schizophr Res2022
35830886Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2022
36351335NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.J Natl Compr Canc Netw2022
35952698The Suspicious Soft Tissue Mass.Surg Clin North Am2022
35952687Wide Resection of Extremity/Truncal Soft Tissue Sarcomas.Surg Clin North Am2022
35921122Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.JAMA Surg2022
35254331Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients.Melanoma Res2022
34383185Restrictive Intraoperative Fluid Rate is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol2022
31188198Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial.Ann Surg2021
33746565Testicular, Spermatic Cord, and Scrotal Soft Tissue Sarcomas: Treatment Outcomes and Patterns of Failure.Sarcoma2021
34157492Barriers to Referral for Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Identified Using a Tailoring Grid Methodology: Interviews with Stakeholders in New York State.J Surg Res2021
34326023Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline.Pract Radiat Oncol2021
30284132The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma.Ann Surg Oncol2019
29681762Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation.Sarcoma2018
29848318Malignant adnexal tumors of the skin: a single institution experience.World J Surg Oncol2018
29752328Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2018
27900630Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons.Ann Surg Oncol2017
29183528Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB Melanoma.Am Surg2017
28591523Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.N Engl J Med2017
24879468Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.Am J Clin Oncol2016
27649955Key gaps in pathologic reporting for appendiceal mucinous neoplasms: time for universal synoptic reporting?Ann Diagn Pathol2016
27283169Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2016
25772798Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resection.J Surg Oncol2015
26633938Homogenous Good Outcome in a Heterogeneous Group of Tumors: An Institutional Series of Outcomes of Superficial Soft Tissue Sarcomas.Sarcoma2015
26350668Incidence of Venous Thromboembolic Events in Mandated Risk Assessment versus Optional DVT Prophylaxis Era at a Large Tertiary Cancer Center.Am Surg2015
27148567Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib.Cold Spring Harb Mol Case Stud2015
26858920Exceptional Clinical Response to BRAF-Targeted Therapy in a Patient with Metastatic Sarcoma.Cureus2015
25916876Does Thoracoscopic Surgery Decrease the Morbidity of Combined Lung and Chest Wall Resection?Ann Thorac Surg2015
26018727Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.Ann Surg Oncol2015
25964567Radiation-induced Chondrosarcoma of the Bladder. Case Report and Review of Literature.Anticancer Res2015
25667281Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.J Clin Oncol2015
25663366Biopsy techniques for soft tissue and bowel sarcomas.J Surg Oncol2015
23793364Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.Ann Surg Oncol2014
25245966The role of radiation therapy in melanoma.Surg Clin North Am2014
24925196Gastrointestinal stromal tumors, version 2.2014.J Natl Compr Canc Netw2014
24717567Soft tissue sarcoma, version 2.2014.J Natl Compr Canc Netw2014
23673557The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis.Oncol Rep2013
23930210A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion.Cancer Med2013
22203182Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132.Ann Surg Oncol2012
22878820Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.J Natl Compr Canc Netw2012
22494912A novel mouse model of isolated limb perfusion for extremity melanoma.J Surg Res2012
22619566Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330.Sarcoma2012
22365526Soft tissue sarcoma. Preface.Surg Oncol Clin N Am2012
22365518Margin status, local recurrence, and survival: correlation or causation?Surg Oncol Clin N Am2012
21492474Thick primary melanoma has a heterogeneous tumor biology: an institutional series.World J Surg Oncol2011
21832164CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma.J Immunol2011
  • 1 - 50 of 88

Recommended Authors

Siriraj Hospital, Mahidol University
Career Start Year 2017
Number of shared co-authors 1
Veterans Affairs Palo Alto Healthcare System, Stanford University School of Medicine
Career Start Year 2017
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 0
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 2009
Number of shared co-authors 1
University of California-Los Angeles
Career Start Year 2006
Number of shared co-authors 4
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 2
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 1
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1999
Number of shared co-authors 3
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 0
University of Toronto
Career Start Year 1996
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Stanford University
Career Start Year 1996
Number of shared co-authors 1
University of California
Career Start Year 1996
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 4
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 3
University of Toronto
Career Start Year 1990
Number of shared co-authors 6
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 1
University of California-Los Angeles
Career Start Year 1990
Number of shared co-authors 2
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 3
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1983
Number of shared co-authors 7
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 1982
Number of shared co-authors 5
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Career Start Year 1977
Number of shared co-authors 2
University of California-Los Angeles
Career Start Year 1969
Number of shared co-authors 2

Collaborators

Johns Hopkins University School of Medicine
Co-authored papers 7
Mayo Clinic
Co-authored papers 7
St Jude Children's Research Hospital
Co-authored papers 6
University of Pittsburgh
Co-authored papers 4
University of Colorado School of Medicine
Co-authored papers 4
David Geffen School of Medicine at University of California los angeles
Co-authored papers 4
University Hospital Zurich
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
34903Fu-Jen Catholic University
Co-authored papers 2
University of Virginia
Co-authored papers 2
Roswell Park Comprehensive Cancer Center
Co-authored papers 2
Mount Sinai Hospital
Co-authored papers 2
University of Pittsburgh
Co-authored papers 2
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 2
Dartmouth-Hitchcock Medical Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The Johns Hopkins Hospital
Co-authored papers 2
James Cancer Center, The Ohio State University
Co-authored papers 2
Co-authored papers 2
University of Pittsburgh Medical Center
Co-authored papers 1
North Shore University Hospital/Cornell University Medical College
Co-authored papers 1
Roswell Park Comprehensive Cancer Center
Co-authored papers 1
Johns Hopkins University
Co-authored papers 1
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 1
University of Tennessee
Co-authored papers 1
Co-authored papers 1
University of Pittsburgh School of Medicine
Co-authored papers 1
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Saint John's Cancer Institute at Saint John's Health Center
Co-authored papers 1